Abstract
Sexual dysfunction is a common problem among patients with ankylosing spondylitis (AS). This study was an open-label study without placebo to assess sexual dysfunction in male patients with AS, and to determine whether sexual function might improve with the use of tumor necrosis factor (TNF)-α blockers. Twenty-two males with AS (age, 29–48 years) were treated for 3 months with TNF-α blockers. Before and after treatment, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) was measured, and all patients completed the International Index of Erectile Function (IIEF) questionnaire, a self-administered measure of sexual dysfunction with five domains: erectile function (EF), intercourse satisfaction (IS), orgasmic function (OF), sexual desire (SD) and overall satisfaction (OS). There were significant improvements in BASDAI after treatment with TNF-α blockers (P<0.001). Anti-TNF-α treated patients showed significant improvements in four out of the five IIEF domains (EF, P<0.001; IS, P<0.001; SD, P=0.006; OS, P=0.033). Among patients with erectile dysfunction, there were significant improvements in three IIEF domains (EF, P=0.006; IS, P=0.007; SD, P=0.018). Only IS domain of IIEF showed a significant correlation with BASDAI (partial correlation coefficient = −0.484, P=0.026). This study showed that anti-TNF-α therapy may improve sexual dysfunction in male AS patients, in addition to reducing disease activity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
van der Linden SM, Valkenburg HA, de Jongh BM, Cats A . The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984; 27: 241–249.
Boonen A, Chorus A, Miedema H, van der Heijde D, van der Tempel H, van der Linden S . Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients. Ann Rheum Dis 2001; 60: 353–358.
Ward MM . Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res 1999; 12: 247–255.
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A . A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286–2291.
Pirildar T, Muezzinoglu T, Pirildar S . Sexual function in ankylosing spondylitis: a study of 65 men. J Urol 2004; 171: 1598–1600.
Dincer U, Cakar E, Kiralp MZ, Dursun H . Assessment of sexual dysfunction in male patients with ankylosing spondylitis. Rheumatol Int 2007; 27: 561–566.
Gorman JD, Sack KE, Davis Jr JC . Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 2002; 346: 1349–1356.
van der Linden S, Valkenburg HA, Cats A . Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361–368.
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A . The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.
Chung TG, Lee TK, Chung S, Lee MS, Kim YS, Ahn TY . The Korean version of the international index of erectile function(IIEF): Reliability and Validation Study. Korean J Urol 1999; 40: 1334–1343.
Hays RD, Morales LS . The RAND-36 measure of health-related quality of life. Ann Med 2001; 33: 350–357.
Han CW, Lee EJ, Iwaya T, Kataoka H, Kohzuki M . Development of the Korean version of Short-Form 36-Item Health Survey: health related QOL of healthy elderly people and elderly patients in Korea. Tohoku J Exp Med 2004; 203: 189–194.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.
Karadag F, Ozcan H, Karul AB, Ceylan E, Cildag O . Correlates of erectile dysfunction in moderate-to-severe chronic obstructive pulmonary disease patients. Respirology (Carlton, Vic) 2007; 12: 248–253.
Hotston MR, Jeremy JY, Bloor J, Koupparis A, Persad R, Shukla N . Sildenafil inhibits the up-regulation of phosphodiesterase type 5 elicited with nicotine and tumour necrosis factor-alpha in cavernosal vascular smooth muscle cells: mediation by superoxide. BJU Int 2007; 99: 612–618.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oh, J., Heo, HM., Kim, YG. et al. The effect of anti-tumor necrosis factor agents on sexual dysfunction in male patients with ankylosing spondylitis: a pilot study. Int J Impot Res 21, 372–375 (2009). https://doi.org/10.1038/ijir.2009.44
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijir.2009.44
Keywords
This article is cited by
-
Tofacitinib monotherapy and erectile dysfunction in rheumatoid arthritis: a pilot observational study
Rheumatology International (2022)
-
The inflammasome NLRP3 plays a dual role on mouse corpora cavernosa relaxation
Scientific Reports (2019)
-
The health-related quality of life of ankylosing spondylitis patients assessed by SF-36: a systematic review and meta-analysis
Quality of Life Research (2016)
-
Effects of tumor necrosis factor-alpha on sexual activity of male patients with ankylosing spondylitis
Clinical Rheumatology (2015)
-
Priapism after tumor necrosis factor alpha inhibitor use
Clinical Rheumatology (2015)